Amgen Inc
AMGN
$434.03+1.86%
End of day · as of Oct 15, 2026, 5:17 PM ET
Mkt cap
$188.67B
EV/Sales
6.37
P/E ratio
27.0
FY2025 Revenue
$36.75B
EPS (TTM)
$16.10
Gross Margin (FY2025)
67.25%
Profit Margin (FY2025)
20.98%
Beta
0.42
Div yield
2.80%
Sector
Healthcare
No recent filings in cache.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 27.0.
Use this AMGN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AMGN income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Amgen Inc (AMGN) is a drug manufacturers - general company in the Healthcare sector.
Latest cached Amgen Inc (AMGN) revenue for Dec 31, 2025 was $36.75B. Net income was $7.71B. Statements: https://lician.com/financials/amgn
Amgen Inc (AMGN) trailing P/E is 27.0 on the latest cached fundamentals snapshot.
Amgen Inc (AMGN) market capitalization is $188.67B on the latest cached snapshot.
Amgen Inc (AMGN) cached previous close $426.11; day range $434.03 – $435.83; volume 4,060,869. Session quote: https://lician.com/quote/amgn
Amgen Inc (AMGN) latest cached earnings event is "AMGN earnings" on Nov 3, 2026. Earnings calendar: https://lician.com/earnings